1. Home
  2. LXRX vs PANL Comparison

LXRX vs PANL Comparison

Compare LXRX & PANL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LXRX
  • PANL
  • Stock Information
  • Founded
  • LXRX 1995
  • PANL 1996
  • Country
  • LXRX United States
  • PANL United States
  • Employees
  • LXRX N/A
  • PANL N/A
  • Industry
  • LXRX Biotechnology: Pharmaceutical Preparations
  • PANL Marine Transportation
  • Sector
  • LXRX Health Care
  • PANL Consumer Discretionary
  • Exchange
  • LXRX Nasdaq
  • PANL Nasdaq
  • Market Cap
  • LXRX 428.8M
  • PANL 361.4M
  • IPO Year
  • LXRX 2000
  • PANL N/A
  • Fundamental
  • Price
  • LXRX $1.52
  • PANL $5.01
  • Analyst Decision
  • LXRX Buy
  • PANL Strong Buy
  • Analyst Count
  • LXRX 5
  • PANL 1
  • Target Price
  • LXRX $3.23
  • PANL $9.00
  • AVG Volume (30 Days)
  • LXRX 2.6M
  • PANL 176.9K
  • Earning Date
  • LXRX 11-11-2025
  • PANL 11-11-2025
  • Dividend Yield
  • LXRX N/A
  • PANL 3.99%
  • EPS Growth
  • LXRX N/A
  • PANL N/A
  • EPS
  • LXRX N/A
  • PANL 0.16
  • Revenue
  • LXRX $58,432,000.00
  • PANL $579,781,169.00
  • Revenue This Year
  • LXRX $67.21
  • PANL $13.00
  • Revenue Next Year
  • LXRX N/A
  • PANL N/A
  • P/E Ratio
  • LXRX N/A
  • PANL $31.10
  • Revenue Growth
  • LXRX 1504.83
  • PANL 15.10
  • 52 Week Low
  • LXRX $0.28
  • PANL $3.93
  • 52 Week High
  • LXRX $2.18
  • PANL $7.09
  • Technical
  • Relative Strength Index (RSI)
  • LXRX 70.28
  • PANL 40.59
  • Support Level
  • LXRX $1.28
  • PANL $5.00
  • Resistance Level
  • LXRX $1.42
  • PANL $5.69
  • Average True Range (ATR)
  • LXRX 0.10
  • PANL 0.15
  • MACD
  • LXRX 0.02
  • PANL -0.06
  • Stochastic Oscillator
  • LXRX 81.00
  • PANL 7.04

About LXRX Lexicon Pharmaceuticals Inc.

Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, also developing LX9851, an orally-delivered small molecule drug candidate, as a treatment for obesity and associated cardiometabolic.

About PANL Pangaea Logistics Solutions Ltd.

Pangaea Logistics Solutions Ltd and its subsidiaries provide seaborne drybulk logistics and transportation services. It transports various drybulk cargoes including grains, coal, iron, ore, pig, iron, hot briquetted iron, bauxite, alumina, cement clinker, dolomite, and limestone. The company provides ocean transportation services to clients utilizing an ocean-going fleet of motor vessels in the Handymax, Supramax, Ultramax, Panamax, and Post-Panamax segments. Its services include cargo loading, cargo discharge, vessel chartering, voyage planning, and technical vessel management. The company derives all of its revenues from contracts of affreightment, voyage charters and time charters. Geographically, it derives key revenue from the United States, followed by Canada, Germany, and others.

Share on Social Networks: